Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T-Cell Immunotherapy for B-Cell Malignancies: A Case Series.

Hematological oncology·2026
Same author

Fibronectin Glomerulopathy: A Case Report of Membranoproliferative Glomerulonephritis.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Shunt estimation in pneumonia of different aetiologies: a non-invasive physiological assessment.

BMJ open respiratory research·2026
Same author

Comment on Gaspari et al. Blood Purification in Hepatic Dysfunction after Liver Transplant or Extensive Hepatectomy: Far from the Best-Case Scenarios. <i>J. Clin. Med.</i> 2024, <i>13</i>, 2853.

Journal of clinical medicine·2025
Same author

[Type I Hyperprolinemia - What about the Kidney?]

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2023
Same author

[A possible relationship between anti-SARS-CoV-2 vaccination and glomerular diseases: food for thought for the nephrologist].

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2022

相关实验视频

Updated: Jun 29, 2026

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.1K

外体肝支持技术:一个比较.

Ivano Riva1, Antonella Marino2, Tino Martino Valetti3

  • 1General Intensive Care Unit, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Piazza OMS, 1, 24127, Bergamo, Italy. iriva@asst-pg23.it.

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
|June 19, 2023
PubMed
概括
此摘要是机器生成的。

与其他体外肝脏支持系统 (ECLS) 相比,CytoSorb在肝功能衰竭患者中显示出优异的解毒效果. 这项研究突出了CytoSorb的重点.

关键词:
身体外的支持.肝功能衰竭 肝功能衰竭肝脏支持 肝脏支持

更多相关视频

Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse
05:30

Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse

Published on: March 9, 2022

9.3K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.5K

相关实验视频

Last Updated: Jun 29, 2026

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
09:29

Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts

Published on: August 13, 2014

15.1K
Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse
05:30

Ex Vivo Hepatic Perfusion Through the Portal Vein in Mouse

Published on: March 9, 2022

9.3K
Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

2.5K

科学领域:

  • 肝病学 肝病学是一种肝病学.
  • 生物医学工程 生物医学工程
  • 关键护理医学 关键护理医学

背景情况:

  • 身体外肝支持系统 (ECLS) 旨在通过去除有毒分子来帮助肝脏排毒.
  • 肝衰竭需要干预来管理有害物质的积累.
  • 评估不同ECLS技术的有效性对于患者管理至关重要.

研究的目的:

  • 在肝衰竭患者中比较各种ECLS系统的排毒疗效.
  • 评估 CytoSorb 与其他体外技术的性能.
  • 确定最有效的ECLS设备,以改善患者的治疗结果.

主要方法:

  • 用不同的ECLS技术治疗的患者的回顾性比较分析.
  • 计算总胆红素 (TB),直接胆红素 (DB) 和胆酸 (BA) 的质量平衡 (MB) 和每小时吸附率.
  • CytoSorb与CPFA,MARS,普罗米修斯和PAP进行比较.

主要成果:

  • CytoSorb对结核病,DB和BA表现出优越的吸附能力.
  • 质量平衡和每小时吸附计算证实了CytoSorb的增强性能.
  • 该研究在评估的ECLS系统中发现了净化效率的显著差异.

结论:

  • 身体外净化是一种潜在的有价值的治疗肝衰竭.
  • 与CPFA,MARS,Prometheus和PAP相比,CytoSorb表现出了更好的表现.
  • 由于其增强的解毒能力,CytoSorb可能是治疗肝衰竭的首选ECLS设备.